A Study to Test How Well Different Doses of BI 3822971 Are Tolerated by People With Advanced Cancer (Solid Tumours)
A Study to Test How Well Different Doses of BI 3822971 Are Tolerated by People With Advanced Cancer (Solid Tumours)
Recruiting · NCT07744152 · Registry updated 2026-09-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Test How Well Different Doses of BI 3822971 Are Tolerated by People With Advanced Cancer (Solid Tumours) | Solid Tumours | Recruiting | Phase 1 | 2026-09-30 | NCT07744152 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Boehringer Ingelheim | 158 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Clínica Universidad de Navarra | Navarra | Spain | 1 |
| Hospital Clinico Universitario de Valencia | Valencia | Spain | 109 |
| Hospital Del Mar | Barcelona | Spain | 98 |
| Hospital Universitari Vall d'Hebron | Barcelona | Spain | 200 |
| Hospital Universitario 12 de Octubre | Madrid | Spain | 359 |
| Klinikum der Universität München AÖR | München | Germany | 6 |
| Nederlands Kanker Instituut - Antoni van Leeuwenhoek Amsterdam (METC AVL) | Amsterdam | Netherlands | 4 |
| Shanghai East Hospital | Shanghai | China | 12 |
| Technische Universität Dresden | Dresden | Germany | 12 |
| UZ Leuven | Leuven | Belgium | 236 |